FR2668488A1 - Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides. - Google Patents

Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides. Download PDF

Info

Publication number
FR2668488A1
FR2668488A1 FR9013324A FR9013324A FR2668488A1 FR 2668488 A1 FR2668488 A1 FR 2668488A1 FR 9013324 A FR9013324 A FR 9013324A FR 9013324 A FR9013324 A FR 9013324A FR 2668488 A1 FR2668488 A1 FR 2668488A1
Authority
FR
France
Prior art keywords
hiv
peptide
sequence
sep
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9013324A
Other languages
English (en)
French (fr)
Other versions
FR2668488B1 (OSRAM
Inventor
Montagnier Luc
Blanchard Alain
Berneman Danielle
Guetard Denise
Bahraoui Elmostafa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9013324A priority Critical patent/FR2668488A1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to EP95112019A priority patent/EP0736542A1/fr
Priority to EP91919407A priority patent/EP0550691B1/fr
Priority to ES91919407T priority patent/ES2087311T3/es
Priority to AT91919407T priority patent/ATE135407T1/de
Priority to DE69117965T priority patent/DE69117965T2/de
Priority to PCT/FR1991/000758 priority patent/WO1992006199A2/fr
Priority to CA002092546A priority patent/CA2092546A1/fr
Priority to DK91919407.6T priority patent/DK0550691T3/da
Publication of FR2668488A1 publication Critical patent/FR2668488A1/fr
Application granted granted Critical
Publication of FR2668488B1 publication Critical patent/FR2668488B1/fr
Priority to GR960401549T priority patent/GR3020185T3/el
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C07K16/114—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1253—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
FR9013324A 1990-09-27 1990-10-26 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides. Granted FR2668488A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR9013324A FR2668488A1 (fr) 1990-10-26 1990-10-26 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides.
EP91919407A EP0550691B1 (fr) 1990-09-27 1991-09-27 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides
ES91919407T ES2087311T3 (es) 1990-09-27 1991-09-27 Peptidos inductores de anticuerpos que inhiben los retrovirus del tipo hiv y anticuerpos dirigidos contra tales peptidos.
AT91919407T ATE135407T1 (de) 1990-09-27 1991-09-27 Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
EP95112019A EP0736542A1 (fr) 1990-09-27 1991-09-27 Peptides inducteurs d'anticorps inhibant des rétrovirus du type HIV et anticorps dirigés contre ces peptides
DE69117965T DE69117965T2 (de) 1990-09-27 1991-09-27 Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
PCT/FR1991/000758 WO1992006199A2 (fr) 1990-09-27 1991-09-27 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides
CA002092546A CA2092546A1 (fr) 1990-09-27 1991-09-27 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides
DK91919407.6T DK0550691T3 (da) 1990-09-27 1991-09-27 Antistofinducerende peptider, som inhiberer retrovira af HIV-typen, og antistoffer, som er specifikke for disse peptider
GR960401549T GR3020185T3 (en) 1990-09-27 1996-06-07 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9013324A FR2668488A1 (fr) 1990-10-26 1990-10-26 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides.

Publications (2)

Publication Number Publication Date
FR2668488A1 true FR2668488A1 (fr) 1992-04-30
FR2668488B1 FR2668488B1 (OSRAM) 1995-04-14

Family

ID=9401614

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9013324A Granted FR2668488A1 (fr) 1990-09-27 1990-10-26 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides.

Country Status (1)

Country Link
FR (1) FR2668488A1 (OSRAM)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593455B2 (en) 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US7012129B2 (en) 2001-09-19 2006-03-14 Tripep Ab Antiviral composition comprising glycine amide
WO2009066241A1 (fr) * 2007-11-22 2009-05-28 Centre National De La Recherche Scientifique (Cnrs) Fragments d'anticorps inhibiteurs de la proteine nef du vih

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187141A1 (en) * 1984-06-06 1986-07-16 Scholl Inc. Sandal having side wall for preventing pronation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187141A1 (en) * 1984-06-06 1986-07-16 Scholl Inc. Sandal having side wall for preventing pronation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 170, no. 3, 16 août 1990, pages 1365-1370; I.H. CHOWDHURY et al.: "Mycoplasma can enhance HIV replication in vitro: A possible cofactor responsible for the progression of AIDS" *
COMPTES RENDUS DE L'ACADEMIE DES SCIENCES, Paris, tôme 311, série III, no. 12, 6 décembre 1990, pages 425-430; L. MONTAGNIER et al.: "Inhibition de l'infectiosité de souches prototypes du VIH par des anticorps dirigés contre une séquence peptidique de mycoplasme" *
GENE, vol. 64, 1988, pages 217-229; J.M. INAMINE et al.: "Nucleotide sequence of the P1 attachment-protein gene of Mycoplasma pneumoniae" *
GENE, vol. 82, 1989, pages 259-267; J.M. INAMINE et al.: "Nucleotide sequence of the MgPa (mgp) operon of Mycoplasma genitalium and comparison to the P1 (mpp) operon of Mycoplasma pneumoniae" *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593455B2 (en) 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US7012129B2 (en) 2001-09-19 2006-03-14 Tripep Ab Antiviral composition comprising glycine amide
WO2009066241A1 (fr) * 2007-11-22 2009-05-28 Centre National De La Recherche Scientifique (Cnrs) Fragments d'anticorps inhibiteurs de la proteine nef du vih
FR2924118A1 (fr) * 2007-11-22 2009-05-29 Centre Nat Rech Scient Fragments d'anticorps inhibiteurs de la proteine nef du vih.
US9512203B2 (en) 2007-11-22 2016-12-06 Centre National De La Recherche Scientifique (Cnrs) Single-domain antibodies that bind to HIV-1 Nef with high affinity

Also Published As

Publication number Publication date
FR2668488B1 (OSRAM) 1995-04-14

Similar Documents

Publication Publication Date Title
EP1042363B1 (fr) Nouveaux immunogenes anti-hiv (toxoides), procedes de preparation et application a la prevention et au traitement du sida
EP0591281B1 (fr) Composes immunogenes a effet notamment anti-cytokine, procede de preparation, compositions pharmaceutiques et kits les renfermant
US7172761B2 (en) Polyvalent immunogen
WO2000075181A1 (fr) FRAGMENTS PROTEIQUES POLYEPITOPIQUES DE LA PROTEINE Nef DE HIV, LEUR OBTENTION ET LEURS UTILISATIONS NOTAMMENT EN VACCINATION
EP0491861A1 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
EP0814834B2 (fr) Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps diriges contre ces immunogenes, procede pour leur preparation et compositions pharmaceutiques les renfermant
De Rossi et al. Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism
EP0550691B1 (fr) Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides
CA2169453A1 (en) Inhibition of hiv mucosal infection
CA2122263A1 (en) Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
FR2668488A1 (fr) Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides.
Stott Towards a vaccine against AIDS: lessons from simian immunodeficiency virus vaccines
Lüke et al. Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derivedex vivo
FR2635532A1 (fr) Particules hbsag recombinantes hybrides : caracteristiques morphologiques de l'antigene hbsag contenant 1 sequence immunogene induisant des anticorps neutralisants diriges contre hiv ou susceptible d'etre reconnue par de tels anticorps; sequences nucleotidiques codant pour de telles particules; vaccins les contenant
EP0835309B1 (fr) Vaccin contre des agents infectieux, composition pour le traitement et la prevention des infections a hiv
WO2002020052A1 (fr) Utilisation de lipopeptides pour l'immunotherapie des sujets vih+
EP1368478B1 (fr) Polypeptide induisant des anticorps neutralisant le vih
EP1423418B1 (fr) Gene env mute, glycoproteine env mutee et utilisations
FR2799974A1 (fr) Complexe deglycosyle proteine env/cd4 et son utilisation pour la vaccination contre le vih
Villinger et al. Induction of long-term protective effects against heterologous challenge in SIVhu-infected macaques
JPH08503704A (ja) Ｇｐ４１変異体とｈｉｖ治療剤としてのそれらの使用
FR2646606A1 (fr) Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations
FR2731355A1 (fr) Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
FR2821556A1 (fr) Utilisation de lipopeptides pour l'immunotherapie des sujets vih+
FR2705970A1 (fr) Identification du gène de l'adhésine de M. Pirum.

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse